Anixa Biosciences, Inc. (FRA:CY71)
Germany
· Delayed Price · Currency is EUR 4.100
+0.040 (0.99%)
At close: Dec 4, 2025
Anixa Biosciences Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.5 | 1.27 | 0.92 | 12.36 | 29.13 | 6.42 | Upgrade
|
| Short-Term Investments | 14.53 | 18.65 | 22.93 | 17.33 | 6.6 | 2.64 | Upgrade
|
| Cash & Short-Term Investments | 16.03 | 19.92 | 23.84 | 29.69 | 35.73 | 9.06 | Upgrade
|
| Cash Growth | -22.73% | -16.44% | -19.68% | -16.91% | 294.47% | 55.04% | Upgrade
|
| Other Receivables | - | 0.17 | 0.27 | 0.05 | - | - | Upgrade
|
| Receivables | - | 0.17 | 0.27 | 0.05 | - | - | Upgrade
|
| Prepaid Expenses | 1.42 | 1.27 | 1.24 | 0.47 | 0.28 | 0.31 | Upgrade
|
| Total Current Assets | 17.45 | 21.36 | 25.36 | 30.2 | 36 | 9.37 | Upgrade
|
| Property, Plant & Equipment | 0.2 | 0.23 | 0.17 | 0.21 | 0.25 | 0.05 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 0.03 | Upgrade
|
| Total Assets | 17.65 | 21.59 | 25.52 | 30.41 | 36.26 | 9.45 | Upgrade
|
| Accounts Payable | 0.28 | 0.53 | 0.21 | 0.27 | 0.14 | 0.23 | Upgrade
|
| Accrued Expenses | 1.75 | 1.95 | 1.77 | 1.73 | 1.1 | 0.9 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.03 | 0.05 | 0.05 | 0.04 | 0.06 | Upgrade
|
| Total Current Liabilities | 2.07 | 2.5 | 2.03 | 2.04 | 1.27 | 1.19 | Upgrade
|
| Long-Term Leases | 0.17 | 0.2 | 0.12 | 0.18 | 0.22 | - | Upgrade
|
| Total Liabilities | 2.24 | 2.7 | 2.15 | 2.21 | 1.49 | 1.19 | Upgrade
|
| Common Stock | 0.33 | 0.32 | 0.31 | 0.31 | 0.3 | 0.24 | Upgrade
|
| Additional Paid-In Capital | 265.25 | 260.43 | 252.22 | 247.12 | 239.93 | 200.35 | Upgrade
|
| Retained Earnings | -248.98 | -240.75 | -228.2 | -218.39 | -204.79 | -191.84 | Upgrade
|
| Treasury Stock | - | -0.01 | - | - | - | - | Upgrade
|
| Total Common Equity | 16.6 | 20 | 24.34 | 29.05 | 35.44 | 8.76 | Upgrade
|
| Minority Interest | -1.18 | -1.11 | -0.97 | -0.85 | -0.67 | -0.5 | Upgrade
|
| Shareholders' Equity | 15.41 | 18.89 | 23.37 | 28.2 | 34.77 | 8.26 | Upgrade
|
| Total Liabilities & Equity | 17.65 | 21.59 | 25.52 | 30.41 | 36.26 | 9.45 | Upgrade
|
| Total Debt | 0.21 | 0.23 | 0.18 | 0.22 | 0.26 | 0.06 | Upgrade
|
| Net Cash (Debt) | 15.82 | 19.69 | 23.67 | 29.47 | 35.47 | 9 | Upgrade
|
| Net Cash Growth | -22.88% | -16.80% | -19.67% | -16.92% | 294.01% | 54.10% | Upgrade
|
| Net Cash Per Share | 0.49 | 0.62 | 0.76 | 0.97 | 1.24 | 0.40 | Upgrade
|
| Filing Date Shares Outstanding | 32.92 | 32.19 | 31.7 | 30.92 | 30.13 | 26.08 | Upgrade
|
| Total Common Shares Outstanding | 32.82 | 32.19 | 31.15 | 30.91 | 30.05 | 24.25 | Upgrade
|
| Working Capital | 15.38 | 18.86 | 23.33 | 28.16 | 34.73 | 8.18 | Upgrade
|
| Book Value Per Share | 0.51 | 0.62 | 0.78 | 0.94 | 1.18 | 0.36 | Upgrade
|
| Tangible Book Value | 16.6 | 20 | 24.34 | 29.05 | 35.44 | 8.76 | Upgrade
|
| Tangible Book Value Per Share | 0.51 | 0.62 | 0.78 | 0.94 | 1.18 | 0.36 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.